Linaprazan Pellets
Rraynex supplies Linaprazan Pellets as pellets in the Potassium-Competitive Acid Blocker (P-CAB) category.
Product overview
Linaprazan is a potassium-competitive acid blocker (P-CAB) developed for acid-related disorders.
Pharmaceutical pellets are small, free-flowing spherical units filled into capsules or compressed into MUPS tablets. Dividing a dose across many pellets gives more reproducible gastric transit and release than a single-unit tablet.
Pharmaceutical applications
- Capsule filling of linaprazan pellets for acid-suppression products.
- Multiparticulate dosage forms where reproducible release matters.
- Formulation development, scale-up and commercial supply programmes.
Product specifications
- Product
- Linaprazan Pellets
- Form
- Pellets
- Therapeutic category
- Potassium-Competitive Acid Blocker (P-CAB)
- Strength
- Agreed per project — share your target strength in the enquiry
- Grade
- IP / BP / USP / EP
- Pack size
- 25/50 kg
- Site certifications
- WHO-GMP, ISO 9001, ISO 14001
Detailed specifications, COA and technical documentation are shared on request.
Supply and enquiries
Rraynex supplies Linaprazan Pellets to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.
Send product enquiry Browse all pellets Manufacturing capabilities